Craig A Tooman, Chief Financial Officer at Silence Therapeutics, holds 619.68K shares in Ondine Biomedical, Inc. (Ticker: GB:OBI), holds ― shares in Silence Therapeutics (Ticker: GB:SLN). Most recently, Craig A Tooman Bought ― shares of Ondine Biomedical, Inc. on May 04, 2024 for an estimated value of 31.25K.
What is the percentage of profitable transactions made by Craig A Tooman?
The percentage of profitable transactions made by Craig A Tooman is 0%.
What is the average return per transaction made by Craig A Tooman?
The average return per transaction made by Craig A Tooman is -15.60%.
What stocks does Craig A Tooman hold?
Craig A Tooman holds: GB:SLN, GB:OBI stocks.
What was Craig A Tooman’s latest transaction?
Craig A Tooman latest transaction was an Informative Buy of 31.25K.
What was Craig A Tooman's most profitable transaction?
Craig A Tooman’s most profitable transaction was an Informative Buy of GB:OBI stock on May 4, 2024. The return on the trade was -3.40%.
What is Craig A Tooman's role in Silence Therapeutics?
Craig A Tooman's role in Silence Therapeutics is Chief Financial Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.